Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth

Koji Taniguchi, Takuma Ishizaki, Toranoshin Ayada, Yuki Sugiyama, Yu Wakabayashi, Takashi Sekiya, Ryusuke Nakagawa, Akihiko Yoshimura

研究成果: Article

27 引用 (Scopus)

抄録

Sprouty proteins have been shown to negatively regulate a variety of receptor tyrosine kinase (RTK) signaling pathways and are considered to be tumor suppressor proteins. The pathophysiological functions of Sproutys in vivo remain to be investigated. In this study, we examined the physiological function of Sprouty4 as an angiogenic regulator, using Sprouty4 knockout (KO) mice and cells.We found that transplanted tumor cells grow much faster in Sprouty4 KO mice than in wild type (WT) mice, which we associate with enhanced neovascularization in the tumors transplanted into Sprouty4 KO mice. Moreover, vascular endothelial growth factor (VEGF)-A-induced angiogenesis and vascular permeability in vivo were enhanced in Sprouty4 KO mice compared with WT mice. Ex vivo angiogenesis, which we induced by VEGF-A, basic fibroblast growth factor (bFGF), and sphingosine-1-phosphate (S1P), was also enhanced in the aortas of Sprouty4 KO mice. We demonstrated that Sprouty4 suppresses Ras-independent VEGF-A and S1P signaling,while it does not affect Ras-dependent VEGF-C signaling. These data indicate that Sprouty4 selectively suppresses Ras-independent angiogenic factor signals and is an important negative regulator of pathophysiological angiogenesis.

元の言語English
ページ(範囲)1648-1654
ページ数7
ジャーナルCancer Science
100
発行部数9
DOI
出版物ステータスPublished - 2009 9

Fingerprint

Knockout Mice
Vascular Endothelial Growth Factor A
Growth
Neoplasms
Vascular Endothelial Growth Factor C
Tumor Suppressor Proteins
Fibroblast Growth Factor 1
Angiogenesis Inducing Agents
Capillary Permeability
Receptor Protein-Tyrosine Kinases
Fibroblast Growth Factor 2
Aorta
Proteins
sphingosine 1-phosphate

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

これを引用

Taniguchi, K., Ishizaki, T., Ayada, T., Sugiyama, Y., Wakabayashi, Y., Sekiya, T., ... Yoshimura, A. (2009). Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth. Cancer Science, 100(9), 1648-1654. https://doi.org/10.1111/j.1349-7006.2009.01214.x

Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth. / Taniguchi, Koji; Ishizaki, Takuma; Ayada, Toranoshin; Sugiyama, Yuki; Wakabayashi, Yu; Sekiya, Takashi; Nakagawa, Ryusuke; Yoshimura, Akihiko.

:: Cancer Science, 巻 100, 番号 9, 09.2009, p. 1648-1654.

研究成果: Article

Taniguchi, K, Ishizaki, T, Ayada, T, Sugiyama, Y, Wakabayashi, Y, Sekiya, T, Nakagawa, R & Yoshimura, A 2009, 'Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth', Cancer Science, 巻. 100, 番号 9, pp. 1648-1654. https://doi.org/10.1111/j.1349-7006.2009.01214.x
Taniguchi K, Ishizaki T, Ayada T, Sugiyama Y, Wakabayashi Y, Sekiya T その他. Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth. Cancer Science. 2009 9;100(9):1648-1654. https://doi.org/10.1111/j.1349-7006.2009.01214.x
Taniguchi, Koji ; Ishizaki, Takuma ; Ayada, Toranoshin ; Sugiyama, Yuki ; Wakabayashi, Yu ; Sekiya, Takashi ; Nakagawa, Ryusuke ; Yoshimura, Akihiko. / Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth. :: Cancer Science. 2009 ; 巻 100, 番号 9. pp. 1648-1654.
@article{74a8f734137c4ea290b761f69d50954f,
title = "Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth",
abstract = "Sprouty proteins have been shown to negatively regulate a variety of receptor tyrosine kinase (RTK) signaling pathways and are considered to be tumor suppressor proteins. The pathophysiological functions of Sproutys in vivo remain to be investigated. In this study, we examined the physiological function of Sprouty4 as an angiogenic regulator, using Sprouty4 knockout (KO) mice and cells.We found that transplanted tumor cells grow much faster in Sprouty4 KO mice than in wild type (WT) mice, which we associate with enhanced neovascularization in the tumors transplanted into Sprouty4 KO mice. Moreover, vascular endothelial growth factor (VEGF)-A-induced angiogenesis and vascular permeability in vivo were enhanced in Sprouty4 KO mice compared with WT mice. Ex vivo angiogenesis, which we induced by VEGF-A, basic fibroblast growth factor (bFGF), and sphingosine-1-phosphate (S1P), was also enhanced in the aortas of Sprouty4 KO mice. We demonstrated that Sprouty4 suppresses Ras-independent VEGF-A and S1P signaling,while it does not affect Ras-dependent VEGF-C signaling. These data indicate that Sprouty4 selectively suppresses Ras-independent angiogenic factor signals and is an important negative regulator of pathophysiological angiogenesis.",
author = "Koji Taniguchi and Takuma Ishizaki and Toranoshin Ayada and Yuki Sugiyama and Yu Wakabayashi and Takashi Sekiya and Ryusuke Nakagawa and Akihiko Yoshimura",
year = "2009",
month = "9",
doi = "10.1111/j.1349-7006.2009.01214.x",
language = "English",
volume = "100",
pages = "1648--1654",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth

AU - Taniguchi, Koji

AU - Ishizaki, Takuma

AU - Ayada, Toranoshin

AU - Sugiyama, Yuki

AU - Wakabayashi, Yu

AU - Sekiya, Takashi

AU - Nakagawa, Ryusuke

AU - Yoshimura, Akihiko

PY - 2009/9

Y1 - 2009/9

N2 - Sprouty proteins have been shown to negatively regulate a variety of receptor tyrosine kinase (RTK) signaling pathways and are considered to be tumor suppressor proteins. The pathophysiological functions of Sproutys in vivo remain to be investigated. In this study, we examined the physiological function of Sprouty4 as an angiogenic regulator, using Sprouty4 knockout (KO) mice and cells.We found that transplanted tumor cells grow much faster in Sprouty4 KO mice than in wild type (WT) mice, which we associate with enhanced neovascularization in the tumors transplanted into Sprouty4 KO mice. Moreover, vascular endothelial growth factor (VEGF)-A-induced angiogenesis and vascular permeability in vivo were enhanced in Sprouty4 KO mice compared with WT mice. Ex vivo angiogenesis, which we induced by VEGF-A, basic fibroblast growth factor (bFGF), and sphingosine-1-phosphate (S1P), was also enhanced in the aortas of Sprouty4 KO mice. We demonstrated that Sprouty4 suppresses Ras-independent VEGF-A and S1P signaling,while it does not affect Ras-dependent VEGF-C signaling. These data indicate that Sprouty4 selectively suppresses Ras-independent angiogenic factor signals and is an important negative regulator of pathophysiological angiogenesis.

AB - Sprouty proteins have been shown to negatively regulate a variety of receptor tyrosine kinase (RTK) signaling pathways and are considered to be tumor suppressor proteins. The pathophysiological functions of Sproutys in vivo remain to be investigated. In this study, we examined the physiological function of Sprouty4 as an angiogenic regulator, using Sprouty4 knockout (KO) mice and cells.We found that transplanted tumor cells grow much faster in Sprouty4 KO mice than in wild type (WT) mice, which we associate with enhanced neovascularization in the tumors transplanted into Sprouty4 KO mice. Moreover, vascular endothelial growth factor (VEGF)-A-induced angiogenesis and vascular permeability in vivo were enhanced in Sprouty4 KO mice compared with WT mice. Ex vivo angiogenesis, which we induced by VEGF-A, basic fibroblast growth factor (bFGF), and sphingosine-1-phosphate (S1P), was also enhanced in the aortas of Sprouty4 KO mice. We demonstrated that Sprouty4 suppresses Ras-independent VEGF-A and S1P signaling,while it does not affect Ras-dependent VEGF-C signaling. These data indicate that Sprouty4 selectively suppresses Ras-independent angiogenic factor signals and is an important negative regulator of pathophysiological angiogenesis.

UR - http://www.scopus.com/inward/record.url?scp=70149089678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70149089678&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2009.01214.x

DO - 10.1111/j.1349-7006.2009.01214.x

M3 - Article

C2 - 19493272

AN - SCOPUS:70149089678

VL - 100

SP - 1648

EP - 1654

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 9

ER -